Skip to main content

SFDA: Methylprednisolone Acetate Injection, causing spinal meningitis, is not registered in the Kingdom


 In view of the monitoring & control role of SFDA and its keenness to keep pace with all information and updates related to safety and security of pharmaceutical products.

And; with reference to the alert published on FDA website and the topics discussed by the World Health Organizations regarding the break-out  of spinal meningitis infection as a result of

using Methylprednisolone Acetate Injection produced by New England Compounding Center (NECC) due to contamination of product packages with fungi .

SFDA would like to explain that t he said product and manufacturer are not registered at SFDA and no lots of this product is released by SFDA and this product is not available in the Kingdom. SFDA follows up the latest updates of the said product and other products.